Wedemeyer H, Alexandrov A, Bogo-molov P, et al. Interim results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection. AASLD 2017, abstract 37.
EASL International Liver Congress (ILC) 2022: virale hepatitis in de spotlights
jul 2022 | Hepatitis, Vaccinatie